Search Within

Lillian Smyth

Formats
  1. Meeting Abstract (22)
  2. Journal Article (20)
Groups
  1. Department of Medicine (40)
  2. Solid Tumor Oncology Division (40)
  3. Breast Medicine Service (33)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (28)
  5. GSK Faculty (27)
  6. Human Oncology and Pathogenesis Program (27)

More Groups

People
  1. Jose Baselga (24)
  2. David Hyman (19)
  3. Clifford Hudis (17)
  4. Larry Norton (17)
  5. David Solit (16)
  6. Chau Dang (15)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (6)
  4. 2019 (5)
  5. 2018 (8)
  6. 2017 (6)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Cancer Research (8)
  3. Cancer Discovery (3)
  4. Annals of Oncology (2)
  5. JCO Precision Oncology (2)
  6. Nature Communications (2)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. American Society of Clinical Oncology (12)
  3. Nature Publishing Group (5)
  4. Oxford University Press (4)
  5. Springer (3)
  6. American Medical Association (1)

More Publishers

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world outcomes of an automated physician support system for genome-driven oncology
    Journal Article

    Tao, J. J.; Eubank, M. H.; Schram, A. M.; Cangemi, N.; Pamer, E.; Rosen, E. Y.; Schultz, N.; Chakravarty, D.; Philip, J.; Hechtman, J. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • AKT mutant allele-specific activation dictates pharmacologic sensitivities
    Meeting Abstract

    Shrestha Bhattarai, T.; Shamu, T.; Patel, S.; Gorelick, A.; Chang, M. T.; Gavrila, E. I.; Gao, J. J.; Donoghue, M. T.; Gao, P. S.; Soumerai, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with human epidermal growth receptor 2 overexpressing metastatic breast cancer: 5-year follow-up
    Journal Article

    Wang, R.; Smyth, L. M.; Iyengar, N.; Chandarlapaty, S.; Modi, S.; Jochelson, M.; Patil, S.; Norton, L.; Hudis, C. A.; Dang, C. T.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Patient-driven discovery, therapeutic targeting, and post-clinical validation of a novel AKT1 fusion-driven cancer
    Journal Article

    Slotkin, E. K.; Diolaiti, D.; Shukla, N. N.; Dela Cruz, F. S.; Clark, J. J.; Gundem, G.; Yellapantula, V. D.; Levine, M. F.; You, D.; Ma, P.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cell-free DNA sequencing in ERBB2-mutant breast cancer patients treated with neratinib and fulvestrant: Exploratory analysis from the phase 2 SUMMIT 'basket' trial
    Meeting Abstract

    Schram, A. M.; Selcuklu, S. D.; Nagy, R. J.; Smyth, L. M.; Eli, L. D.; Cutler, R. E.; Lalani, A. S.; Hyman, D. M.; Lanman, R. B.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Influence of age on the clinical outcome of breast cancer for men and the development of second primary cancers
    Journal Article

    Cronin, P. A.; Romanoff, A.; Zabor, E. C.; Stempel, M.; Eaton, A.; Smyth, L. M.; Ho, A. Y.; Morrow, M.; El-Tamer, M.; Gemignani, M. L.
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save